SCHEMBL8555433

SCHEMBL8555433

CCCC(c1cccc2c1C(=O)NC2=O)N1CCOCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCG P05129 7/20 0.39
PRKCB P05771 6/20 0.39
PRKCA P17252 6/20 0.39
DPP4 P27487 1/20 0.38
GSK3B P49841 8/20 0.37
PRKCE Q02156 3/20 0.37
PRKCD Q05655 2/20 0.37
CDK1 P06493 2/20 0.37
CCNB2 O95067 1/20 0.37
PDGFRB P09619 1/20 0.37
CCNB1 P14635 1/20 0.37
PDGFRA P16234 1/20 0.37
PRKACA P17612 1/20 0.37
PRKACG P22612 1/20 0.37
PRKACB P22694 1/20 0.37
KDR P35968 1/20 0.37
CAMK2B Q13554 1/20 0.37
CAMK2G Q13555 1/20 0.37
CAMK2D Q13557 1/20 0.37
CCNB3 Q8WWL7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8559526 0.87 CAMK2B (0.34) PRKCGPRKCBPRKCADPP4GSK3B
SCHEMBL8664540 0.74 DRD2 (0.52) SLC6A4
SCHEMBL1256987 0.72 KDM4E (0.40) GSK3BKDM4EALDH1A1HPGDHSD17B10
SCHEMBL34459998 0.72 MAPT (0.43) PRKCGPRKCBPRKCAGSK3BOPRD1
SCHEMBL34460000 0.70 ALDH1A1 (0.38) KDM4EALDH1A1HSD17B10MEN1MAPT
SCHEMBL12875827 0.70 MC4R (0.50) DPP4KDM4EALDH1A1NPSR1SLC6A2
SCHEMBL9136212 0.70 ALDH1A1 (0.38) GSK3BKDM4EALDH1A1HPGDHSD17B10
SCHEMBL8559801 0.70 SLC6A2 (0.35) GSK3BKDM4EALDH1A1HPGDHSD17B10
SCHEMBL30876940 0.69 KDM4E (0.43) GSK3BKDM4EALDH1A1HPGDHSD17B10
SCHEMBL8074204 0.69 POLB (0.37) GSK3BKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575954-B1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process MEDIOLANUM FARMACEUTICI SRL (IT) 1998-09-02 EP disclosed
US-5424451-A Used as cholinesterase activity inhibitors MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1995-06-13 US disclosed
US-5302593-A Aminoalkylcarbamic esters of eseroline suitable for use as chlorinesterase activity inhibitors MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1994-04-12 US disclosed
EP-0575954-A1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process MEDIOLANUM FARMACEUTICI S.P.A. (IT) 1993-12-29 EP disclosed